Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
34.21
+0.53 (1.57%)
At close: Sep 1, 2026, 4:00 PM EDT
34.21
0.00 (0.00%)
After-hours: Sep 1, 2026, 4:10 PM EDT
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $2.04 billion as of September 1, 2026. Its market cap has decreased by -6.78% in one year.
Market Cap
2.04B
Enterprise Value
1.11B
1-Year Change
-6.78%
Ranking
Category
Stock Price
$34.21
ChartMarket Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $2.04B, an increase of 122.24%. That is a compound annual growth rate of 6.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.04B | 28.67% |
| Dec 31, 2025 | 1.59B | -15.30% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
| Jul 24, 2013 | 919.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 2.11B |
| UroGen Pharma | 2.11B |
| ADMA Biologics | 2.10B |
| Zymeworks | 2.09B |
| Nanobiotix | 2.04B |
| Vericel | 2.04B |
| Xencor | 2.03B |
| Stoke Therapeutics | 2.01B |